
CT-1
CAS No. 1983924-33-9
CT-1( CT1 | CT 1 )
Catalog No. M27867 CAS No. 1983924-33-9
CT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
![]() ![]() |
10MG | 581 | Get Quote |
![]() ![]() |
25MG | 888 | Get Quote |
![]() ![]() |
50MG | 1242 | Get Quote |
![]() ![]() |
100MG | 1674 | Get Quote |
![]() ![]() |
500MG | 3348 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCT-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.
-
DescriptionCT-1 is a DNA minor groove ligand and causes p53-dependent breast cancer cell apoptosis.
-
In Vitro——
-
In Vivo——
-
SynonymsCT1 | CT 1
-
PathwayApoptosis
-
Targetp53
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1983924-33-9
-
Formula Weight500.525
-
Molecular FormulaC29H23F3N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1ccc(Cn2cc(CN3C\C(=C/c4ccccc4F)C(=O)\C(C3)=C\c3ccccc3F)nn2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moreau, M. F.; Michelot, J.; Papon, J.; Bayle, M.; Labarre, P.; Madelmont, J. C.; Parry, D.; Boire, J. Y.; Moins, N.; et al. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-?diethylaminoethyl)?-?4-?iodobenzamide derivatives as melanoma imaging agents. Nuclear Medicine and Biology (1995), 22(6), 737-47.
molnova catalog



related products
-
C16 Ceramide
C16 Ceramide (Palmitoyl Ceramide) is a naturally occurring small molecule that activates p53 by directly and selectively binding to it.
-
Napellonine
Napellonine shows favorable anti-tumor activity in preliminary pharmacological verification trials including cell proliferation and molecular docking assays.
-
Pifithrin-α, p-Nitro...
Pifithrin-α, p-Nitro, Cyclic (PFN-α) is cell-permeable and active-form inhibitor of p53.